These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4149200)

  • 1. [Comparative characteristics of antiarrhythmic activity of certain drugs in patients with thyrotoxic auricular fibrillation].
    Rom-Bugoslavskaia ES; Levchenko TP
    Vrach Delo; 1973 Aug; 8():62-4. PubMed ID: 4149200
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotoxic atrial fibrillation.
    Parmar MS
    MedGenMed; 2005 Jan; 7(1):74. PubMed ID: 16369379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative antiarrhythmic activity of beta-N-hexamethyleneimino-P-butoxypropiophenone, quinidine and novocaine amide in aconitine auricular fibrillation and flutter in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(4):415-8. PubMed ID: 5357458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiarrhythmic drugs in atrial fibrillation].
    Brembilla-Perrot B
    Rev Prat; 2002 Jun; 52(12):1317-23. PubMed ID: 12187895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
    Levey GS
    Med Clin North Am; 1975 Sep; 59(5):1193-9. PubMed ID: 240093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should we discontinue antiarrhythmic therapy for atrial fibrillation after coronary artery bypass grafting? A prospective randomized study.
    Izhar U; Ad N; Rudis E; Milgalter E; Korach A; Viola N; Levi E; Asraff G; Merin G; Elami A
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):401-6. PubMed ID: 15678052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic specifics in atrial fibrillation in hyperthyroidism. Study of 14 cases].
    Kamoun M; Haffani M; Basdeh L; Abid H; Kraiem S; Slimane H; Haddad A
    Tunis Med; 2003 Dec; 81(12):932-6. PubMed ID: 14986528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of obsidan on platelet hemostasis in patients with atrial fibrillation].
    Antiuf'ev VF; Sukhanov VA
    Klin Med (Mosk); 1983 Oct; 61(10):64-7. PubMed ID: 6139503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alprenolol-quinidine combination in the treatment of chronic atrial fibrillation].
    Levi GF; Proto C
    Clin Ter; 1970 Oct; 55(2):115-21. PubMed ID: 4396235
    [No Abstract]   [Full Text] [Related]  

  • 12. Ten years experience with the use of B-adrenergic blockers in the pre-operative preparation of thyrotoxic patients.
    Bashir AY; Nasef A; Ibrahim AH; Kenawi MM; El-Malek WA; Ageeb M
    J Egypt Med Assoc; 1978; 61(1-2):1-9. PubMed ID: 41011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of drug therapy in atrial fibrillation].
    Kelle L; Bota L
    Z Arztl Fortbild (Jena); 1981 May; 75(10):492-6. PubMed ID: 6118978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atrial fibrillation: rhythm or rate control?].
    Le Heuzey JY; Saïd MA; Paziaud O
    Rev Prat; 2002 Jun; 52(12):1335-8. PubMed ID: 12187898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
    Sommers HM; Jennings RB
    Arch Intern Med; 1972 May; 129(5):780-9. PubMed ID: 5025900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The function of newer antiarrhythmic drugs under special consideration of beta blocking adrenergic agents.
    Shalsha KG
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():201-11. PubMed ID: 4402617
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
    Gettes LS
    Cardiovasc Clin; 1970; 2(2):211-37. PubMed ID: 4149974
    [No Abstract]   [Full Text] [Related]  

  • 19. Post-cardioversion drug therapy in cases of atrial fibrillation.
    Thakur AK; Shreenivas
    J Indian Med Assoc; 1974 Sep; 63(5):145-50. PubMed ID: 4448913
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic role of propranolol.
    Fitzgerald JD
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):289-91. PubMed ID: 4391518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.